← FDA Drug Approvals (Drugs@FDA)
ATELVIA
NDA · New Drug Application · Sponsor: APIL · Approved 2010-10-08
Drug application
- FDA Application #
NDA022560- Application type
- New Drug Application
- Brand name
- ATELVIA
- Generic name
- RISEDRONATE SODIUM
- Active ingredients
- RISEDRONATE SODIUM
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- APIL
- Manufacturer
- Allergan, Inc.
- First approval
- 2010-10-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown